The Homer1 gene is a synaptic scaffolding gene that appears to regulate baseline brain activity in the prefrontal cortex, the region most involved in attention. Research in mice suggests that lower Homer1 levels can quiet neural background noise and sharpen focus. These findings are early-stage, but they point toward a fundamentally different approach to treating ADHD.
What is the Homer1 gene?
Homer1 encodes a protein that sits at the postsynaptic density of glutamatergic synapses, the junctions where excitatory signals pass between neurons. It acts as a scaffold, organizing receptor complexes and helping regulate how strongly a synapse responds to incoming signals. Research has shown that Homer1 interacts with metabotropic glutamate receptor 5 (mGlu5) and Shank proteins, and that these interactions change dynamically when neurons fire (Stillman et al., 2022) [3].
Think of Homer1 as a volume knob at the synapse. It helps set how loud or quiet the baseline signal is. When Homer1 levels are high, the synapse tends to be more active at rest. When levels are lower, the baseline quiets down.
Homer1 exists in multiple forms, or isoforms. The short isoforms (like Homer1a) and the longer isoforms serve different functions. Homer1a is an "immediate early gene" product, meaning the brain produces it rapidly in response to neural activity. This distinction between short and long isoforms turns out to be important for understanding how Homer1 relates to attention.
Earlier research had already connected Homer1a to ADHD-like behaviors. A 2013 study found that Homer1a was significantly down-regulated in the brains of spontaneously hypertensive rats, a commonly used animal model of ADHD. When researchers artificially reduced Homer1a in normal rats, those animals developed increased locomotor activity, non-selective attention, and impaired learning, a behavioral profile that resembles ADHD (Hong et al., 2013) [2]. That same study noted that methylphenidate, a first-line ADHD medication, can up-regulate Homer1a expression.
So Homer1 was already on the radar. But the recent findings from Rockefeller University added something unexpected.
What did the new research find?
Researchers at Rockefeller University used an unbiased forward genetics approach, studying 200 genetically diverse mice on measures of pre-attentive processing, to identify genes with large effects on attention. Through genetic mapping, they identified a small region on chromosome 13 that drove approximately 19% of the variation in attentional performance. Further analysis pinpointed Homer1 as the causative gene within that locus (Gershon et al., 2024) [1].
The key finding: when the short isoforms of Homer1 were down-regulated in the prefrontal cortex during early postnatal development, adult mice showed improved performance across multiple measures of attention. This was not a subtle effect. A single gene region accounted for roughly a fifth of the variation in attentional traits in these genetically diverse animals.
"The gene we found has a striking effect on attention and is relevant to humans." Priya Rajasethupathy, Rockefeller University, 2025 [6]
The mechanistic work revealed something particularly interesting. Prefrontal Homer1 down-regulation was associated with up-regulation of GABAergic receptors, the brain's primary inhibitory system, in those same cells. This enhanced inhibitory influence, combined with dynamic neuromodulatory coupling, produced a distinctive pattern: very low prefrontal cortex activity during baseline periods of the task, but targeted elevations when a cue appeared. The mice responded faster and more accurately (Gershon et al., 2024) [1].
By contrast, mice with high Homer1 levels and poor attentional performance showed uniformly elevated prefrontal activity throughout the task, both during baseline periods and when cues appeared.
How does Homer1 relate to attention?
Glutamate signaling, which Homer1 regulates, helps the brain prioritize relevant information over distractions.
Attention depends on the brain's ability to distinguish meaningful signals from constant background input. The prefrontal cortex plays a central role in this filtering process. Homer1 appears to influence how effectively the prefrontal cortex separates what matters from what does not, by setting the volume of baseline neural activity.
To understand why this matters, consider what happens when you try to hear someone speaking at a loud party. If the background noise is high, even a clear voice gets lost. But if the room quiets down, the same voice becomes easy to hear. The Homer1 research suggests something analogous happens in the prefrontal cortex.
Mice with lower Homer1 levels had quieter prefrontal activity at rest. When a relevant cue appeared, the signal stood out sharply against that quiet background. Mice with higher Homer1 levels had noisy prefrontal activity all the time, so the cue signal was harder to distinguish from the baseline (Gershon et al., 2024).
This connects to a broader understanding of what causes ADHD at the brain level. ADHD involves disruptions in prefrontal cortex function, and the neurotransmitter systems that regulate attention (dopamine, norepinephrine, and now potentially glutamate and GABA) all converge in this region. Homer1 sits at the intersection of excitatory glutamate signaling and inhibitory GABA regulation, which positions it as a potential upstream regulator of the balance between the two.
What is the signal-to-noise problem in ADHD?
ADHD can be understood, at least partly, as a signal-to-noise ratio problem in the brain. The prefrontal cortex needs to amplify relevant information (signal) while suppressing irrelevant input (noise). When this ratio is poor, attention suffers. The Homer1 research provides a molecular mechanism that may contribute to this imbalance.
In the Rockefeller study, high-performing mice showed a clear pattern: low baseline activity punctuated by sharp, targeted responses to cues. This is a high signal-to-noise ratio. Poor-performing mice showed the opposite: high baseline activity with relatively smaller cue responses. Same signal strength, but the noise floor was too high for the signal to stand out (Gershon et al., 2024) [1].
If you have ever tried to focus in a noisy coffee shop versus a quiet library, you have experienced the external version of this problem. The Homer1 research suggests that some brains may generate their own internal version of the noisy coffee shop, with the prefrontal cortex running too "loud" at baseline.
| Feature | High-attention mice (low Homer1) | Low-attention mice (high Homer1) |
|---|---|---|
| Baseline prefrontal activity | Low, quiet | Elevated, noisy |
| Response to attention cue | Sharp, targeted increase | Modest increase above already-high baseline |
| Signal-to-noise ratio | High | Low |
| GABAergic receptor levels | Up-regulated (more inhibition) | Lower inhibitory tone |
| Task performance | Faster, more accurate responses | Slower, less accurate responses |
This framework also aligns with what many adults with ADHD describe: not a lack of effort or motivation, but a sense that their brain is too busy, too full of competing signals, to lock onto the one thing that matters. If you recognize this pattern in yourself, you can take a free ADHD screening questionnaire to help organize your experiences before talking with a clinician.
The glutamate and GABA connection extends beyond Homer1 alone. A gene set analysis of 931 individuals with ADHD found that common variants within glutamatergic genes were associated with severity of hyperactivity and impulsivity symptoms, and GABAergic gene variants showed a nominal association with response inhibition (Naaijen et al., 2017) [4]. This suggests that the excitatory-inhibitory balance Homer1 helps regulate is relevant to ADHD in humans, not only in mice.
What could this mean for ADHD treatment?
Current ADHD medications boost dopamine and norepinephrine, but Homer1 research points to glutamate as another target.
The Homer1 findings suggest a treatment concept that is fundamentally different from current approaches. Most ADHD medications, including stimulants like methylphenidate and amphetamines, work primarily by increasing dopamine and norepinephrine activity in prefrontal circuits. They turn up the signal. The Homer1 research suggests an alternative: turning down the noise.
The study authors stated this directly:
"A therapeutic strategy focused on reducing prefrontal activity and increasing SNR, rather than uniformly elevating PFC activity, may complement the use of stimulants to improve attention." Gershon et al., 2024 [1]
This is an important distinction. Current stimulant medications are effective for many people, but they work by broadly increasing prefrontal cortex activity. A Homer1-informed approach would instead aim to reduce baseline neural noise, potentially through enhancing GABAergic inhibition or modulating glutamate signaling at the synapse. The two strategies are not mutually exclusive; they could complement each other.
Quieting versus stimulating: a comparison
| Approach | Mechanism | Current status |
|---|---|---|
| Stimulant medication | Increases dopamine and norepinephrine, raising overall prefrontal activity | Established first-line treatment with decades of clinical evidence |
| Non-stimulant medication (e.g., atomoxetine) | Increases norepinephrine selectively | Established alternative, especially when stimulants are not suitable |
| Homer1-based approach (theoretical) | Reduces baseline neural noise by enhancing inhibitory tone | Preclinical only; demonstrated in mice, no human trials announced |
It is worth noting that Homer1 sits within the glutamatergic signaling system, which is a different pathway from the dopaminergic and noradrenergic systems targeted by current medications. This means a Homer1-informed treatment would not simply be a variation on existing drugs. It would represent a genuinely new pharmacological target. Understanding the genetic basis of ADHD helps explain why researchers are looking beyond dopamine for new treatment avenues.
The broader genetic picture reinforces this direction. A large 2026 exome-sequencing study of nearly 9,000 individuals with ADHD identified rare coding variants in genes involved in synapse function and GABAergic neurons, among other pathways (Demontis et al., 2026) [5]. While that study focused on different genes (MAP1A, ANO8, ANK2), the convergence on synaptic and inhibitory biology supports the idea that the excitatory-inhibitory balance is relevant to ADHD at the genetic level.
How far away are Homer1-based treatments?
All Homer1 attention findings come from mouse studies. No human clinical trials targeting Homer1 for ADHD have been announced. The path from a mouse genetics discovery to an approved human treatment is long, typically spanning a decade or more, and most preclinical findings do not survive the translation to human medicine.
Several specific hurdles remain:
- Species translation. Mouse prefrontal cortex anatomy and genetics differ from human. A gene that accounts for 19% of attentional variation in mice may have a smaller, larger, or different effect in humans.
- Developmental timing. The strongest effects in the Rockefeller study occurred when Homer1 was down-regulated during early postnatal development, a critical window. It is not yet clear whether modifying Homer1-related pathways in adulthood would produce similar benefits (ScienceDaily, 2026) [7].
- Safety. Homer1 is involved in synaptic function throughout the brain, not just in the prefrontal cortex. Any drug targeting this pathway would need to be highly specific to avoid unintended effects elsewhere.
- Shared biology with other conditions. Homer1 has been linked to autism and schizophrenia as well as ADHD (Rockefeller University, 2025) [6]. This shared biology could be an advantage (a single pathway relevant to multiple conditions) or a complication (difficulty targeting ADHD-specific symptoms without affecting other processes).
What is well-established versus what is still emerging
| Well-established | Still emerging or uncertain |
|---|---|
| Homer1 encodes a synaptic scaffolding protein at glutamatergic synapses | Whether Homer1 variation has the same attentional effect in humans as in mice |
| ADHD has a large genetic component, with both common and rare variants contributing | Whether modifying Homer1 pathways in adulthood (rather than during development) would improve attention |
| Glutamatergic and GABAergic gene variants are associated with ADHD symptom severity in humans | Whether a drug targeting Homer1-related pathways can be made specific enough for clinical use |
| Current stimulant medications increase prefrontal cortex activity | Whether a "quieting" approach would complement or replace stimulant treatment in practice |
The honest summary: this is a genuinely interesting discovery that identifies a new biological mechanism for attention and a potential new pharmacological direction. It is not a treatment that anyone can access now, and it may never become one. But it expands the scientific understanding of what goes wrong in attention disorders and opens a research direction that was not previously available.
Is there a connection between Homer1 and mindfulness?
The Homer1 research raises an interesting parallel with mindfulness and meditation practices. Both involve, at least conceptually, quieting background mental activity to improve focus. Research on mindfulness approaches for ADHD has shown that meditation practices can improve attention and reduce mind-wandering in some adults with ADHD, though the evidence base is still developing.
The parallel is suggestive but should not be overstated. Mindfulness operates at the behavioral and experiential level. Homer1 operates at the molecular and synaptic level. There is no direct evidence that meditation changes Homer1 expression. Still, the convergence is worth noting: both lines of research point toward the idea that reducing internal noise, rather than simply trying harder to focus, may be a productive strategy for attention difficulties.
For adults managing ADHD now, this convergence offers a practical takeaway. While Homer1-targeted treatments remain years away at best, strategies that reduce internal mental noise, including mindfulness, environmental modifications, and structured routines, align with the same general principle the Homer1 research supports. If you are wondering whether your attention difficulties might reflect ADHD, you can try our online ADHD self-assessment as a first step toward understanding your experience.
Infographic: key points about homer1 gene adhd.
Homer1 research opens a potential new treatment pathway beyond traditional dopamine-focused ADHD medications.
Frequently asked questions
What is the Homer1 gene?
Homer1 is a gene that produces a scaffolding protein found at excitatory synapses in the brain. It helps organize receptor complexes at the postsynaptic density and appears to regulate how active or quiet neurons are at rest, particularly in the prefrontal cortex (Stillman et al., 2022).
Does Homer1 cause ADHD?
No single gene causes ADHD. Homer1 is one of many genes that appear to influence attention-related brain function. The Rockefeller study found that Homer1 variation accounted for about 19% of attentional variation in genetically diverse mice (Gershon et al., 2024), but ADHD in humans involves many genetic and environmental factors.
How does Homer1 affect attention?
Research in mice suggests that lower levels of Homer1's short isoforms in the prefrontal cortex lead to increased inhibitory (GABAergic) tone. This quiets baseline neural activity, creating a better signal-to-noise ratio when attention cues appear. The result is faster, more accurate responses to relevant stimuli.
Are there Homer1-based treatments available now?
No. All Homer1 attention findings come from animal studies. No human clinical trials targeting Homer1 for ADHD have been announced. The path from preclinical discovery to approved treatment typically takes a decade or more, and many preclinical findings do not translate successfully to humans.
How is this different from current ADHD medications?
Current stimulant medications primarily increase dopamine and norepinephrine activity, raising overall prefrontal cortex activity. A Homer1-informed approach would aim to reduce baseline neural noise through enhanced inhibitory tone, a fundamentally different mechanism. The study authors suggest these approaches could potentially complement each other.
Is Homer1 only relevant to ADHD?
No. Homer1 has also been linked to autism spectrum disorder and schizophrenia, conditions that involve early sensory processing differences (Rockefeller University, 2025). This shared biology suggests overlapping pathways across neurodevelopmental conditions.
What does "signal-to-noise ratio" mean in the context of ADHD?
It refers to the brain's ability to distinguish relevant information (signal) from irrelevant background activity (noise). In the Homer1 research, mice with better attention had low baseline prefrontal activity that spiked sharply when a cue appeared. Mice with poor attention had high baseline activity, making cues harder to detect.
Does this research apply to adults or only children?
The mouse study involved developmental manipulation during early postnatal periods, and it remains unclear whether modifying Homer1-related pathways in adulthood would produce similar benefits. ADHD affects approximately 2.5% of adults worldwide (Demontis et al., 2026), and whether this research direction will eventually apply to adult treatment is an open question.
Can meditation change Homer1 levels?
There is no direct evidence that meditation or mindfulness practices alter Homer1 expression. The parallel between Homer1 research (quieting neural noise improves attention) and mindfulness (reducing internal mental chatter) is conceptually interesting but remains speculative at this stage.
What role does glutamate play in ADHD?
Glutamate is the brain's primary excitatory neurotransmitter. Gene set analyses have found associations between glutamatergic gene variants and ADHD symptom severity, particularly hyperactivity and impulsivity (Naaijen et al., 2017). Homer1 sits within this glutamatergic signaling system, which is why its role in attention is drawing research interest.
